Treatment of chronic migraine

Current Pain and Headache Reports

Volumn 15, Issue 1, 2011, Pages 64-69

  Diener, Hans Christoph ^a   Holle, Dagny ^a   Dodick, David ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

Botulinum toxin; Chronic migraine; Topiramate; Treatment

Indexed keywords

ANTIMIGRAINE AGENT; BOTULINUM TOXIN; FLUOXETINE; GABAPENTIN; MEMANTINE; ONABOTULINUMTOXIN A; PLACEBO; PREGABALIN; TIZANIDINE; TOPIRAMATE; UNCLASSIFIED DRUG; ZONISAMIDE;

ABNORMAL THINKING; ANALGESIA; ARTICLE; ASTHENIA; CHRONIC DAILY HEADACHE; CONSTIPATION; DISEASE DURATION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; HUMAN; LOW DRUG DOSE; MAINTENANCE THERAPY; MEDICATION ERROR; MIGRAINE; MOOD CHANGE; QUALITY OF LIFE; SIDE EFFECT; SOMNOLENCE; TRANSFORMED MIGRAINE; TREATMENT DURATION; TREATMENT RESPONSE; XEROSTOMIA;

ANTICONVULSANTS; BOTULINUM TOXINS, TYPE A; CHRONIC DISEASE; FRUCTOSE; HUMANS; MIGRAINE DISORDERS;

EID: 79551532088     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-010-0159-x     Document Type: Article

References (39)

1. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24 Suppl 1:9-160.
2. J Olesen M Bousser H Diener, et al. 2006 New appendix criteria open for a broader concept of chronic migraine Cephalalgia 26 742 746 1:STN:280: DC%2BD283mt1Gruw%3D%3D 10.1111/j.1468-2982.2006.01172.x 16686915
3. ME Bigal RB Lipton 2008 Excessive acute migraine medication use and migraine progression Neurology 71 1821 1828 1:CAS:528:DC%2BD1cXhtlylurjI 10.1212/01.wnl.0000335946.53860.1d 19029522
4. J Natoli A Manack B Dean, et al. 2010 Global prevalence of chronic migraine: a systematic review Cephalalgia 30 599 609 1:STN:280: DC%2BC3cfntVSqsQ%3D%3D 19614702
5. DC Buse A Manack D Serrano C Turkel RB Lipton 2010 Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers J. Neurol. Neurosurg. Psychiatr. 81 428 432 1:STN:280:DC%2BC3c3ivFGisA%3D%3D 10.1136/jnnp.2009.192492 20164501
6. Blumenfeld A, Varon S, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS). Cephalalgia 2010. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20813784 [Accessed October 3, 2010].
7. ME Bigal D Serrano M Reed RB Lipton 2008 Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment Neurology 71 559 566 10.1212/01.wnl.0000323925.29520.e7 18711108 This article provides an excellent clinical characterization of chronic migraineurs
8. Z Katsarava S Schneeweiss T Kurth, et al. 2004 Incidence and predictors for chronicity of headache in patients with episodic migraine Neurology 62 788 790 1:STN:280:DC%2BD2c7hslektw%3D%3D 15007133
9. AI Scher WF Stewart JA Ricci RB Lipton 2003 Factors associated with the onset and remission of chronic daily headache in a population-based study Pain 106 81 89 1:STN:280:DC%2BD3srgsVGjuw%3D%3D 10.1016/S0304-3959(03)00293-8 14581114 (Pubitemid 37329617)
10. ME Bigal RB Lipton 2009 Overuse of acute migraine medications and migraine chronification Curr Pain Headache Rep. 13 301 307 10.1007/s11916-009- 0048-3 19586594
11. ME Bigal RB Lipton 2009 What predicts the change from episodic to chronic migraine? Curr. Opin. Neurol. 22 269 276 10.1097/WCO.0b013e32832b2387 19381087
12. AI Scher LA Midgette RB Lipton 2008 Risk factors for headache chronification Headache. 48 16 25 10.1111/j.1526-4610.2007.00970.x 18184281
13. D Dodick S Silberstein 2006 Central sensitization theory of migraine: clinical implications Headache. 46 Suppl 4 S182 191 10.1111/j.1526-4610.2006. 00602.x 17078850 (Pubitemid 44656903)
14. M De Felice MH Ossipov R Wang, et al. 2010 Triptan-induced latent sensitization: a possible basis for medication overuse headache Ann. Neurol 67 325 337 20373344 The authors describe a new pathophysiological concept for medication-overuse headache
15. M De Felice F Porreca 2009 Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache Cephalalgia 29 1277 1284 10.1111/j.1468-2982.2009.01873.x 19438917
16. DW Dodick SD Silberstein 2007 Migraine prevention Pract Neurol. 7 383 393 1:STN:280:DC%2BD2snovFWnsg%3D%3D 10.1136/jnnp.2007.134023 18024778 (Pubitemid 350237714)
17. D Mei D Ferraro G Zelano, et al. 2006 Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine Clin Neuropharmacol. 29 269 275 1:CAS:528:DC%2BD28XptF2rt7g%3D 10.1097/01.WNF. 000022888.49044.99 16960472 (Pubitemid 44440000)
18. M Silvestrini M Bartolini M Coccia, et al. 2003 Topiramate in the treatment of chronic migraine Cephalalgia. 23 820 824 1:STN:280: DC%2BD3svkvFOiug%3D%3D 10.1046/j.1468-2982.2003.00592.x 14510929 (Pubitemid 37255424)
19. M Bartolini M Silvestrini R Taffi, et al. 2005 Efficacy of topiramate and valproate in chronic migraine Clin Neuropharmacol. 28 277 279 1:CAS:528:DC%2BD2MXht1yitb%2FP 10.1097/01.wnf.0000192136.46145.44 16340383 (Pubitemid 44378618)
20. V Limmroth D Biondi J Pfeil S Schwalen 2007 Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache Headache 47 13 21 10.1111/j.1526-4610.2007.00648.x 17355489 (Pubitemid 46096052)
21. SD Silberstein RB Lipton DW Dodick, et al. 2007 Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial Headache 47 170 180 10.1111/j.1526-4610.2006.00684.x 17300356
22. H Diener G Bussone JC Van Oene, et al. 2007 Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study Cephalalgia. 27 814 823 10.1111/j.1468-2982.2007.01326.x 17441971 (Pubitemid 46961730)
23. H Diener DW Dodick PJ Goadsby, et al. 2009 Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse Cephalalgia 29 1021 1027 10.1111/j.1468-2982.2009.01859.x 19735529 This is an excellent review on the efficacy of topiramate in patients with chronic migraine with and without medication overuse
24. RB Lipton WF Stewart J Sawyer JG Edmeads 2001 Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire Headache 41 854 861 1:STN:280:DC%2BD3MnnsVWquw%3D%3D 11703471
25. M Mula M Viana R Jauch, et al. 2009 Health-related quality of life measures and psychiatric comorbidity in patients with migraine Eur. J. Neurol. 16 9 1017 1021 1:STN:280:DC%2BD1MrotFWksw%3D%3D 10.1111/j.1468-1331.2009.02636.x 19473352
26. S Silberstein H Diener R Lipton, et al. 2008 Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate Headache 48 1087 1095 10.1111/j.1526-4610.2008.01185.x 18687081 (Pubitemid 351952087)
27. KR Aoki 2005 Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A Neurotoxicology 26 785 793 1:CAS:528: DC%2BD2MXhtFWhsLnJ 10.1016/j.neuro.2005.01.017 16002144 (Pubitemid 41427518)
28. SK Aurora M Gawel JL Brandes S Pokta AM Vandenburgh 2007 Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study Headache 47 486 499 10.1111/j.1526-4610. 2007.00853.x 17445098 (Pubitemid 47057220)
29. JR Saper NT Mathew EW Loder R DeGryse AM VanDenburgh 2007 A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine Pain Med. 8 478 485 10.1111/j.1526-4637.2006.00168.x 17716321 (Pubitemid 47316329)
30. SD Silberstein H Göbel R Jensen, et al. 2006 Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study Cephalalgia 26 790 800 1:STN:280:DC%2BD28zmtlaquw%3D%3D 10.1111/j.1468-2982.2006.01114.x 16776693 (Pubitemid 43882987)
31. SK Aurora DW Dodick CC Turkel, et al. 2010 OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 793 803 1:STN:280:DC%2BC3cjgt1Sjtg%3D%3D 10.1177/0333102410364676 20647170
32. HC Diener DW Dodick SK Aurora, et al. 2010 OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 804 814 1:STN:280:DC%2BC3cjgt1Sjtw%3D%3D 10.1177/0333102410364677 20647171
33. • Dodick D, Turkel C, DrGryse R, et al. OnabotulinumA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical programme. Headache 2010, in press. This article provides pooled PREEMPT study results showing the efficacy of botulinum toxin in chronic migraine treatment.
34. NT Mathew A Rapoport J Saper, et al. 2001 Efficacy of gabapentin in migraine prophylaxis Headache 41 119 128 1:STN:280:DC%2BD3MzmvVKktw%3D%3D 10.1046/j.1526-4610.2001.111006119.x 11251695 (Pubitemid 32209899)
35. EP Calandre JM Garcia-Leiva F Rico-Villademoros JS Vilchez CM Rodriguez-Lopez 2010 Pregabalin in the treatment of chronic migraine: an open-label study Clin Neuropharmacol. 33 35 39 1:CAS:528:DC%2BC3cXht12gtLY%3D 10.1097/WNF.0b013e3181bf1dbe 19935409
36. JR Saper AE Lake DT Cantrell PK Winner JR White 2002 Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study Headache. 42 470 482 10.1046/j.1526-4610.2002.02122.x 12167135 (Pubitemid 37011819)
37. JR Saper SD Silberstein AE Lake ME Winters 1994 Double-blind trial of fluoxetine: chronic daily headache and migraine Headache 34 497 502 1:STN:280:DyaK2M%2FpsFKhtg%3D%3D 10.1111/j.1526-4610.1994.hed3409497.x 8002320 (Pubitemid 24355870)
38. A Ashkenazi A Benlifer J Korenblit SD Silberstein 2006 Zonisamide for migraine prophylaxis in refractory patients Cephalalgia 26 1199 1202 1:STN:280:DC%2BD28rjs12jtA%3D%3D 10.1111/j.1468-2982.2006.01191.x 16961786 (Pubitemid 44359340)
39. M Bigal A Rapoport F Sheftell D Tepper S Tepper 2008 Memantine in the preventive treatment of refractory migraine Headache 48 1337 1342 10.1111/j.1526-4610.2008.01083.x 19031499